1
|
Ryapolov P, Vasilyeva A, Kalyuzhnaya D, Churaev A, Sokolov E, Shel’deshova E. Magnetic Fluids: The Interaction between the Microstructure, Macroscopic Properties, and Dynamics under Different Combinations of External Influences. NANOMATERIALS (BASEL, SWITZERLAND) 2024; 14:222. [PMID: 38276740 PMCID: PMC10819141 DOI: 10.3390/nano14020222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 01/12/2024] [Accepted: 01/15/2024] [Indexed: 01/27/2024]
Abstract
Magnetic fluids were historically the first active nano-dispersion material. Despite over half a century of research, interest in these nano-objects continues to grow every year. This is due to the impressive development of nanotechnology, the synthesis of nanoscale structures, and surface-active systems. The unique combination of fluidity and magnetic response allows magnetic fluids to be used in engineering devices and biomedical applications. In this review, experimental results and fundamental theoretical approaches are systematized to predict the micro- and macroscopic behavior of magnetic fluid systems under different external influences. The article serves as working material for both experienced scientists in the field of magnetic fluids and novice specialists who are just beginning to investigate this topic.
Collapse
Affiliation(s)
- Petr Ryapolov
- Department of Nanotechnology, Microelectronics, General and Applied Physics, Faculty of Natural Sciences, Southwest State University, 50 Let Oktyabrya Street, 94, 305040 Kursk, Russia; (A.V.); (D.K.); (A.C.); (E.S.); (E.S.)
| | | | | | | | | | | |
Collapse
|
2
|
Magnetoresponsive Functionalized Nanocomposite Aggregation Kinetics and Chain Formation at the Targeted Site during Magnetic Targeting. Pharmaceutics 2022; 14:pharmaceutics14091923. [PMID: 36145671 PMCID: PMC9503060 DOI: 10.3390/pharmaceutics14091923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2022] [Revised: 09/05/2022] [Accepted: 09/07/2022] [Indexed: 11/17/2022] Open
Abstract
Drug therapy for vascular disease has been promoted to inhibit angiogenesis in atherosclerotic plaques and prevent restenosis following surgical intervention. This paper investigates the arterial depositions and distribution of PEG-functionalized magnetic nanocomposite clusters (PEG_MNCs) following local delivery in a stented artery model in a uniform magnetic field produced by a regionally positioned external permanent magnet; also, the PEG_MNCs aggregation or chain formation in and around the implanted stent. The central concept is to employ one external permanent magnet system, which produces enough magnetic field to magnetize and guide the magnetic nanoclusters in the stented artery region. At room temperature (25 °C), optical microscopy of the suspension model’s aggregation process was carried out in the external magnetic field. According to the optical microscopy pictures, the PEG_MNC particles form long linear aggregates due to dipolar magnetic interactions when there is an external magnetic field. During magnetic particle targeting, 20 mL of the model suspensions are injected (at a constant flow rate of 39.6 mL/min for the period of 30 s) by the syringe pump in the mean flow (flow velocity is Um = 0.25 m/s, corresponding to the Reynolds number of Re = 232) into the stented artery model. The PEG_MNC clusters are attracted by the magnetic forces (generated by the permanent external magnet) and captured around the stent struts and the bottom artery wall before and inside the implanted stent. The colloidal interaction among the MNC clusters was investigated by calculating the electrostatic repulsion, van der Waals and magnetic dipole-dipole energies. The current work offers essential details about PEG_MNCs aggregation and chain structure development in the presence of an external magnetic field and the process underlying this structure formation.
Collapse
|
3
|
Ferrara B, Belbekhouche S, Habert D, Houppe C, Vallée B, Bourgoin-Voillard S, Cohen JL, Cascone I, Courty J. Cell surface nucleolin as active bait for nanomedicine in cancer therapy: a promising option. NANOTECHNOLOGY 2021; 32:322001. [PMID: 33892482 DOI: 10.1088/1361-6528/abfb30] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Accepted: 04/23/2021] [Indexed: 06/12/2023]
Abstract
Conventional chemotherapy used against cancer is mostly limited due to their non-targeted nature, affecting normal tissue and causing undesirable toxic effects to the affected tissue. With the aim of improving these treatments both therapeutically and in terms of their safety, numerous studies are currently being carried out using nanoparticles (NPs) as a vector combining tumor targeting and carrying therapeutic tools. In this context, it appears that nucleolin, a molecule over-expressed on the surface of tumor cells, is an interesting therapeutic target. Several ligands, antagonists of nucleolin of various origins, such as AS1411, the F3 peptide and the multivalent pseudopeptide N6L have been developed and studied as therapeutic tools against cancer. Over the last ten years or so, numerous studies have been published demonstrating that these antagonists can be used as tumor targeting agents with NPs from various origins. Focusing on nucleolin ligands, the aim of this article is to review the literature recently published or under experimentation in our research team to evaluate the efficacy and future development of these tools as anti-tumor agents.
Collapse
Affiliation(s)
- Benedetta Ferrara
- Université Paris-Est Creteil, Immunorégulation et Biothérapie, INSERM U955, Hôpital Henri Mondor, F-94010 Créteil, France
| | - Sabrina Belbekhouche
- Université Paris-Est Creteil, CNRS, Institut Chimie et Matériaux Paris Est, UMR 7182, 2 Rue Henri Dunant, F-94320 Thiais, France
| | - Damien Habert
- Université Paris-Est Creteil, Immunorégulation et Biothérapie, INSERM U955, Hôpital Henri Mondor, F-94010 Créteil, France
| | - Claire Houppe
- Université Paris-Est Creteil, Immunorégulation et Biothérapie, INSERM U955, Hôpital Henri Mondor, F-94010 Créteil, France
| | - Benoit Vallée
- Université Paris-Est Creteil, Immunorégulation et Biothérapie, INSERM U955, Hôpital Henri Mondor, F-94010 Créteil, France
| | - Sandrine Bourgoin-Voillard
- Université Paris-Est Creteil, Immunorégulation et Biothérapie, INSERM U955, Hôpital Henri Mondor, F-94010 Créteil, France
- Université Grenoble Alpes, Laboratory of Fundamental and Applied Bioenergetics/Prométhée Proteomic Platform, UGA-INSERM U1055-CHUGA, Grenoble, France
- Université Grenoble Alpes, CNRS, Grenoble INP, CHU Grenoble Alpes, TIMC, PROMETHEE Proteomic Platform, Grenoble, France
| | - José L Cohen
- Université Paris-Est Creteil, Immunorégulation et Biothérapie, INSERM U955, Hôpital Henri Mondor, F-94010 Créteil, France
| | - Ilaria Cascone
- Université Paris-Est Creteil, Immunorégulation et Biothérapie, INSERM U955, Hôpital Henri Mondor, F-94010 Créteil, France
| | - José Courty
- Université Paris-Est Creteil, Immunorégulation et Biothérapie, INSERM U955, Hôpital Henri Mondor, F-94010 Créteil, France
| |
Collapse
|
4
|
Ivanov AO, Zubarev A. Chain Formation and Phase Separation in Ferrofluids: The Influence on Viscous Properties. MATERIALS 2020; 13:ma13183956. [PMID: 32906703 PMCID: PMC7559013 DOI: 10.3390/ma13183956] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Revised: 06/12/2020] [Accepted: 09/02/2020] [Indexed: 12/15/2022]
Abstract
Ferrofluids have attracted considerable interest from researchers and engineers due to their rich set of unique physical properties that are valuable for many industrial and biomedical applications. Many phenomena and features of ferrofluids' behavior are determined by internal structural transformations in the ensembles of particles, which occur due to the magnetic interaction between the particles. An applied magnetic field induces formations, such as linear chains and bulk columns, that become elongated along the field. In turn, these structures dramatically change the rheological and other physical properties of these fluids. A deep and clear understanding of the main features and laws of the transformations is necessary for the understanding and explanation of the macroscopic properties and behavior of ferrofluids. In this paper, we present an overview of experimental and theoretical works on the internal transformations in these systems, as well as on the effect of the internal structures on the rheological effects in the fluids.
Collapse
Affiliation(s)
- Alexey O. Ivanov
- Department of Theoretical and Mathematical Physics, Ural Federal University, Lenin Ave. 51, 620000 Ekaterinburg, Russia;
- M.N. Mikheev Institute of Metal Physics of the Ural Branch of the Russian Academy of Sciences, 620990 Ekaterinburg, Russia
| | - Andrey Zubarev
- Department of Theoretical and Mathematical Physics, Ural Federal University, Lenin Ave. 51, 620000 Ekaterinburg, Russia;
- M.N. Mikheev Institute of Metal Physics of the Ural Branch of the Russian Academy of Sciences, 620990 Ekaterinburg, Russia
- Correspondence: ; Tel.: +7-343-2160-765
| |
Collapse
|
5
|
Abstract
Iron oxide nanoparticles are the basic components of the most promising magneto-responsive systems for nanomedicine, ranging from drug delivery and imaging to hyperthermia cancer treatment, as well as to rapid point-of-care diagnostic systems with magnetic nanoparticles. Advanced synthesis procedures of single- and multi-core iron-oxide nanoparticles with high magnetic moment and well-defined size and shape, being designed to simultaneously fulfill multiple biomedical functionalities, have been thoroughly evaluated. The review summarizes recent results in manufacturing novel magnetic nanoparticle systems, as well as the use of proper characterization methods that are relevant to the magneto-responsive nature, size range, surface chemistry, structuring behavior, and exploitation conditions of magnetic nanosystems. These refer to particle size, size distribution and aggregation characteristics, zeta potential/surface charge, surface coating, functionalization and catalytic activity, morphology (shape, surface area, surface topology, crystallinity), solubility and stability (e.g., solubility in biological fluids, stability on storage), as well as to DC and AC magnetic properties, particle agglomerates formation, and flow behavior under applied magnetic field (magnetorheology).
Collapse
|
6
|
Nedyalkova M, Donkova B, Romanova J, Tzvetkov G, Madurga S, Simeonov V. Iron oxide nanoparticles - In vivo/in vitro biomedical applications and in silico studies. Adv Colloid Interface Sci 2017; 249:192-212. [PMID: 28499604 DOI: 10.1016/j.cis.2017.05.003] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2017] [Revised: 04/28/2017] [Accepted: 05/02/2017] [Indexed: 12/22/2022]
Abstract
The review presents a broad overview of the biomedical applications of surface functionalized iron oxide nanoparticles (IONPs) as magnetic resonance imaging (MRI) agents for sensitive and precise diagnosis tool and synergistic combination with other imaging modalities. Then, the recent progress in therapeutic applications, such as hyperthermia is discussed and the available toxicity data of magnetic nanoparticles concerning in vitro and in vivo biomedical applications are addressed. This review also presents the available computer models using molecular dynamics (MD), Monte Carlo (MC) and density functional theory (DFT), as a basis for a complete understanding of the behaviour and morphology of functionalized IONPs, for improving NPs surface design and expanding the potential applications in nanomedicine.
Collapse
Affiliation(s)
- Miroslava Nedyalkova
- Faculty of Chemistry and Pharmacy, University of Sofia "St. Kl. Okhridski". J. Bourchier Blvd. 1, 1164 Sofia, Bulgaria.
| | - Borjana Donkova
- Faculty of Chemistry and Pharmacy, University of Sofia "St. Kl. Okhridski". J. Bourchier Blvd. 1, 1164 Sofia, Bulgaria
| | - Julia Romanova
- Faculty of Chemistry and Pharmacy, University of Sofia "St. Kl. Okhridski". J. Bourchier Blvd. 1, 1164 Sofia, Bulgaria
| | - George Tzvetkov
- Faculty of Chemistry and Pharmacy, University of Sofia "St. Kl. Okhridski". J. Bourchier Blvd. 1, 1164 Sofia, Bulgaria
| | - Sergio Madurga
- Materials Science and Physical Chemistry Department & Research Institute of Theoretical and Computational Chemistry (IQTCUB) of Barcelona University (UB), C/Martí i Franquès, 1, 08028 Barcelona, Catalonia, Spain
| | - Vasil Simeonov
- Faculty of Chemistry and Pharmacy, University of Sofia "St. Kl. Okhridski". J. Bourchier Blvd. 1, 1164 Sofia, Bulgaria
| |
Collapse
|
7
|
Magnetic iron oxide nanoparticles: Recent trends in design and synthesis of magnetoresponsive nanosystems. Biochem Biophys Res Commun 2015; 468:442-53. [DOI: 10.1016/j.bbrc.2015.08.030] [Citation(s) in RCA: 98] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2015] [Accepted: 08/08/2015] [Indexed: 01/01/2023]
|
8
|
Lyer S, Tietze R, Unterweger H, Zaloga J, Singh R, Matuszak J, Poettler M, Friedrich RP, Duerr S, Cicha I, Janko C, Alexiou C. Nanomedical innovation: the SEON-concept for an improved cancer therapy with magnetic nanoparticles. Nanomedicine (Lond) 2015; 10:3287-304. [PMID: 26472623 DOI: 10.2217/nnm.15.159] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Nanomedicine offers tremendous opportunities for the development of novel therapeutic and diagnostic tools. During the last decades, extensive knowledge was gained about stabilizing and the coating of nanoparticles, their functionalization for drug binding and drug release and possible strategies for therapies and diagnostics of different diseases. Most recently, more and more emphasis has been placed on nanotoxicology and nanosafety aspects. The section of experimental oncology and nanomedicine developed a concept for translating this knowledge into clinical application of magnetic drug targeting for the treatment of cancer and other diseases using superparamagnetic iron oxide nanoparticles. This approach includes reproducible synthesis, detailed characterization, nanotoxicological testing, evaluation in ex vivo models, preclinical animal studies and production of superparamagnetic iron oxide nanoparticles according to good manufacturing practice regulations.
Collapse
Affiliation(s)
- Stefan Lyer
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany
| | - Rainer Tietze
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany
| | - Harald Unterweger
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany
| | - Jan Zaloga
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany
| | - Raminder Singh
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany
| | - Jasmin Matuszak
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany
| | - Marina Poettler
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany
| | - Ralf P Friedrich
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany
| | - Stephan Duerr
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany.,Department of Otorhinolaryngology, Section of Phoniatrics & Pediatric Audiology, Head & Neck Surgery, University Hospital Erlangen, Bohlenplatz 21, 91054 Erlangen, Germany
| | - Iwona Cicha
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany
| | - Christina Janko
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany
| | - Christoph Alexiou
- Department of Otorhinolaryngology, Section of Experimental Oncology & Nanomedicine (SEON), Head & Neck Surgery, Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany
| |
Collapse
|
9
|
Zaloga J, Stapf M, Nowak J, Pöttler M, Friedrich RP, Tietze R, Lyer S, Lee G, Odenbach S, Hilger I, Alexiou C. Tangential Flow Ultrafiltration Allows Purification and Concentration of Lauric Acid-/Albumin-Coated Particles for Improved Magnetic Treatment. Int J Mol Sci 2015; 16:19291-307. [PMID: 26287178 PMCID: PMC4581297 DOI: 10.3390/ijms160819291] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2015] [Accepted: 08/09/2015] [Indexed: 02/06/2023] Open
Abstract
Superparamagnetic iron oxide nanoparticles (SPIONs) are frequently used for drug targeting, hyperthermia and other biomedical purposes. Recently, we have reported the synthesis of lauric acid-/albumin-coated iron oxide nanoparticles SEON(LA-BSA), which were synthesized using excess albumin. For optimization of magnetic treatment applications, SPION suspensions need to be purified of excess surfactant and concentrated. Conventional methods for the purification and concentration of such ferrofluids often involve high shear stress and low purification rates for macromolecules, like albumin. In this work, removal of albumin by low shear stress tangential ultrafiltration and its influence on SEON(LA-BSA) particles was studied. Hydrodynamic size, surface properties and, consequently, colloidal stability of the nanoparticles remained unchanged by filtration or concentration up to four-fold (v/v). Thereby, the saturation magnetization of the suspension can be increased from 446.5 A/m up to 1667.9 A/m. In vitro analysis revealed that cellular uptake of SEON(LA-BSA) changed only marginally. The specific absorption rate (SAR) was not greatly affected by concentration. In contrast, the maximum temperature Tmax in magnetic hyperthermia is greatly enhanced from 44.4 °C up to 64.9 °C by the concentration of the particles up to 16.9 mg/mL total iron. Taken together, tangential ultrafiltration is feasible for purifying and concentrating complex hybrid coated SPION suspensions without negatively influencing specific particle characteristics. This enhances their potential for magnetic treatment.
Collapse
Affiliation(s)
- Jan Zaloga
- Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany.
| | - Marcus Stapf
- Institute for Diagnostic and Interventional Radiology, University Hospital Jena, 07747 Jena, Germany.
| | - Johannes Nowak
- Chair of Magnetofluiddynamics, Measuring and Automation Technology, Technische Universität Dresden, 01069 Dresden, Germany.
| | - Marina Pöttler
- Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany.
| | - Ralf P Friedrich
- Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany.
| | - Rainer Tietze
- Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany.
| | - Stefan Lyer
- Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany.
| | - Geoffrey Lee
- Division of Pharmaceutics, Friedrich Alexander University Erlangen-Nuremberg, 91058 Erlangen, Germany.
| | - Stefan Odenbach
- Chair of Magnetofluiddynamics, Measuring and Automation Technology, Technische Universität Dresden, 01069 Dresden, Germany.
| | - Ingrid Hilger
- Institute for Diagnostic and Interventional Radiology, University Hospital Jena, 07747 Jena, Germany.
| | - Christoph Alexiou
- Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany.
| |
Collapse
|
10
|
Li YW, Chen ZG, Zhao ZS, Li HL, Wang JC, Zhang ZM. Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma. World J Gastroenterol 2015; 21:4275-4283. [PMID: 25892879 PMCID: PMC4394090 DOI: 10.3748/wjg.v21.i14.4275] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/20/2014] [Revised: 11/17/2014] [Accepted: 12/08/2014] [Indexed: 02/06/2023] Open
Abstract
AIM: To prepare the specific magnetic resonance (MR) probes for detection of hepatocellular carcinoma (HCC) using one-pot method.
METHODS: The carboxylated dextran-coated nanoparticles were conjugated with anti-α-fetoprotein (anti-AFP) or anti-glypican 3 (anti-GPC3) antibodies through 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride/N-hydroxysuccinimide (EDC/NHS)-mediated reaction to synthesize the probes. The physical and chemical properties of the probes were determined by transmission electron microscopy (TEM) and dynamic light scattering, and the relaxivity was compared to uncombined ultrasmall superparamagnetic iron oxide nanoparticles (USPIONs) using a 1.5T clinical MR scanner. The binding efficiency of the antibodies to nanoparticles was measured with an ultraviolet-visible spectrophotometer. In addition, the probes were incubated with targetable cells in vitro.
RESULTS: The superparamagnetic MR probes (anti-GPC3-USPION probe and anti-AFP-USPION probe) were synthesized using one-pot method. Their mean hydrodynamic diameter was 47 nm with a broader slight size distribution. The coupling efficiency of carboxylated dextran-coated ultrasmall superparamagnetic iron oxide (USPIO) with anti-GPC3 or anti-AFP antibody was 15.9% and 88.8%, respectively. Each of the USPIO nanoparticles may bind 3 GPC3 antibodies or 12 AFP antibodies. The statistical analysis showed no significance (P > 0.05) in shortening the T1 and T2 values when comparing the USPIO-AFP or USPIO-GPC3 to USPIO. Analysis of TEM images revealed that anti-GPC3-USPION probes and anti-AFP-USPION probes could specifically enter into the HepG2 cell by combining with the GPC3 receptors or AFP receptors, whereas the HepG2 cell sample incubated with USPIONs showed no or few nanoparticles in the cytoplasm.
CONCLUSION: The synthesized probes using one-pot method can be used for in vitro experimental study and have potential clinical application in MR imaging for detection of hepatocellular carcinomas.
Collapse
|